{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:04:34Z","timestamp":1787065474636,"version":"build-2736575974"},"reference-count":29,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Wroclaw Medical University","doi-asserted-by":"publisher","award":["SUBK.C140.22.063"],"award-info":[{"award-number":["SUBK.C140.22.063"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Continuous development of molecular and immunophenotypic techniques enables more precise diagnoses and more accurate assessment of prognosis in myelodysplastic syndromes (MDS). However, the relationship between genetic alterations and immunophenotype remains very poorly understood. The analysis included 30 patients diagnosed at a tertiary center who were eligible for azacitidine treatment. Next-generation sequencing (NGS) was performed at the start of the study to assess the mutation status of 40 genes associated with MDS pathogenesis. In addition, multiparametric flow cytometry (MFC) was performed to assess the ELN score (Ogata score) and, additionally, to detect an abnormal CD11b\/HLA-DR and CD11b\/CD13 expression pattern. In the studied patient population, higher ELN score results were found in patients with mutations in epigenetic modifiers and pathogenic mutations of the tumor suppressor genes. Signal pathway mutations were associated with lower platelet counts at diagnosis. The results of this study indicate a correlation between molecular abnormalities and deviations in cell immunophenotype. Investigating this correlation may, in the future, allow the development of new scales that allow a more sensitive and specific diagnosis of MDS and a more precise prediction of its course.<\/jats:p>","DOI":"10.3390\/ijms26157382","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:00:41Z","timestamp":1753884041000},"page":"7382","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrating Molecular Alterations with Immunophenotype and Clinical Characteristics in Myelodysplastic Syndromes: A Single-Center Study"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6064-296X","authenticated-orcid":false,"given":"Maciej","family":"Majcherek","sequence":"first","affiliation":[{"name":"Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6370-2206","authenticated-orcid":false,"given":"Krzysztof","family":"Przeorski","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8837-6517","authenticated-orcid":false,"given":"Aleksandra","family":"Mroczkowska-B\u0119karciak","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Nogaj","sequence":"additional","affiliation":[{"name":"Laboratory of Flow Cytometry and Cytomorphology, Department of Hematology and Bone Marrow Transplantation, University Hospital in Wroclaw, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donata","family":"Szymczak","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"},{"name":"Laboratory of Flow Cytometry and Cytomorphology, Department of Hematology and Bone Marrow Transplantation, University Hospital in Wroclaw, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7674-7863","authenticated-orcid":false,"given":"Anna","family":"Kopszak","sequence":"additional","affiliation":[{"name":"Statistical Analysis Centre, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2812-4702","authenticated-orcid":false,"given":"Krzysztof","family":"Kujawa","sequence":"additional","affiliation":[{"name":"Statistical Analysis Centre, Wroclaw Medical University, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-2116","authenticated-orcid":false,"given":"Paula","family":"Jab\u0142onowska-Babij","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Tomasiewicz","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-3180","authenticated-orcid":false,"given":"Agnieszka","family":"Szeremet","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Wr\u00f3bel","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6641-0182","authenticated-orcid":false,"given":"Anna","family":"Czy\u017c","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"ref_1","first-page":"9","article-title":"Perspective: Clonal Hematopoiesis of Indeterminate Potential and Its Distinction from Myelodysplastic Syndromes","volume":"126","author":"Steensma","year":"2018","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2352-3026(23)00340-X","article-title":"Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: A prospective cohort study","volume":"11","author":"Cargo","year":"2024","journal-title":"Lancet Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41408-024-01031-9","article-title":"ARTICLE Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes\/neoplasms","volume":"14","author":"Lee","year":"2024","journal-title":"Blood Cancer J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/cyto.b.22108","article-title":"Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet\/International Myelodysplastic Syndrome Flow Cytometry Working Group","volume":"104","author":"Porwit","year":"2023","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e2017017","DOI":"10.4084\/mjhid.2017.017","article-title":"Diagnostic utility of flow cytometry in myelodysplastic syndromes","volume":"9","author":"Picone","year":"2017","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood-2021-146367","article-title":"Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS)\u2014Composition of a Prognostic FCM-Score for Overall Survival","volume":"138","author":"Oelschlaegel","year":"2021","journal-title":"Blood."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/cyto.b.22057","article-title":"Identification of a specific immunophenotype associated with a consistent pattern of genetic mutations including SRFS2 and gene expression profile in MDS","volume":"104","author":"Walter","year":"2023","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1002\/cncr.25353","article-title":"Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: Correlation to cytomorphology, cytogenetics, and clinical data","volume":"116","author":"Kern","year":"2010","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e13028","DOI":"10.1111\/sji.13028","article-title":"The diagnostic and prognostic significance of flow cytometric bone marrow assessment in myelodysplastic syndromes according to the European LeukemiaNet recommendations in single-centre real-life experience","volume":"94","author":"Majcherek","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.2009.005801","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: Report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes","volume":"94","author":"Alhan","year":"2009","journal-title":"Haematologica"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000489042","article-title":"ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications","volume":"86","author":"Valent","year":"2018","journal-title":"Pathobiology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ajh.25018","article-title":"A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1\/2 mutations and improved outcome","volume":"93","author":"Mason","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jha2.317","article-title":"The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?","volume":"3","author":"Cook","year":"2021","journal-title":"EJHaem"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s00277-023-05384-2","article-title":"Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: Correlations with morphology and mutational profile","volume":"102","author":"Guarnera","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"390.e1","DOI":"10.1016\/j.jtct.2023.03.008","article-title":"TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia","volume":"29","author":"Mason","year":"2023","journal-title":"Transplant. Cell. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s00277-021-04608-7","article-title":"Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients","volume":"100","author":"Strapatsas","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","article-title":"Genetics of MDS","volume":"133","author":"Ogawa","year":"2019","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/ijmr.IJMR_924_18","article-title":"Evaluation of multiparametric flow cytometry in diagnosis & prognosis of myelodysplastic syndrome in India","volume":"152","author":"Dhingra","year":"2020","journal-title":"Indian J. Med. Res."},{"key":"ref_19","first-page":"7449","article-title":"Simplified flow cytometry scoring for diagnosis and prognosis of myelodysplastic symptom","volume":"12","author":"Guo","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Elshoeibi, A.M., Badr, A., Elsayed, B., Metwally, O., Elshoeibi, R., Elhadary, M.R., Elshoeibi, A., Attya, M.A., Khadadah, F., and Alshurafa, A. (2023). Integrating AI and ML in Myelodysplastic Syndrome Diagnosis: State-of-the-Art and Future Prospects. Cancers, 16.","DOI":"10.3390\/cancers16010065"},{"key":"ref_21","first-page":"2435","article-title":"Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry","volume":"108","author":"Clichet","year":"2023","journal-title":"Haematologica"},{"key":"ref_22","first-page":"2271","article-title":"Challenging the status flow: How artificial intelligence is advancing diagnosis of myelodysplastic neoplasms","volume":"108","author":"Duetz","year":"2023","journal-title":"Haematologica"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classi fi cation of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.annonc.2020.11.002","article-title":"Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up y5 behalf of the ESMO Guidelines Committee","volume":"32","author":"Fenaux","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular International Prognostic Scoring System for Myelodysplastic Syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3324\/haematol.2013.097188","article-title":"Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia","volume":"99","author":"Picone","year":"2014","journal-title":"Haematologica"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kontandreopoulou, C.N., Kalopisis, K., Viniou, N.A., and Diamantopoulos, P. (2022). The genetics of myelodysplastic syndromes and the opportunities for tailored treatments. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.989483"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Saygin, C., and Godley, L.A. (2021). Genetics of Myelodysplastic Syndromes. Cancers, 13.","DOI":"10.3390\/cancers13143380"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7382\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:19:10Z","timestamp":1760033950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":29,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157382"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157382","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}